These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15290849)

  • 21. Hepatic gene expression of NK4, an HGF-antagonist/angiogenesis inhibitor, suppresses liver metastasis and invasive growth of colon cancer in mice.
    Wen J; Matsumoto K; Taniura N; Tomioka D; Nakamura T
    Cancer Gene Ther; 2004 Jun; 11(6):419-30. PubMed ID: 15017381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NK4 gene therapy targeting HGF-Met and angiogenesis.
    Matsumoto K; Nakamura T
    Front Biosci; 2008 Jan; 13():1943-51. PubMed ID: 17981681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Growth suppression of subcutaneous tumor by CT26 expressing NK4 in syngeneic mice].
    Kubota T; Fujiwara H; Amaike H; Takashima K; Inada S; Atsuji K; Yoshimura M; Matsumoto K; Nakamura T; Yamagishi H
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2258-60. PubMed ID: 12484049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of NK4 gene transfection on tumor growth of human pancreatic cancer xenograft in nude mice].
    Lai RX; Zhang SN; Nakamura T; Yuan SZ
    Ai Zheng; 2005 Oct; 24(10):1191-5. PubMed ID: 16219131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation.
    Fukunaka Y; Iwanaga K; Morimoto K; Kakemi M; Tabata Y
    J Control Release; 2002 Apr; 80(1-3):333-43. PubMed ID: 11943409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor suppression induced by intratumor administration of adenovirus vector expressing NK4, a 4-kringle antagonist of hepatocyte growth factor, and naive dendritic cells.
    Kikuchi T; Maemondo M; Narumi K; Matsumoto K; Nakamura T; Nukiwa T
    Blood; 2002 Dec; 100(12):3950-9. PubMed ID: 12393687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo.
    Davies G; Mason MD; Martin TA; Parr C; Watkins G; Lane J; Matsumoto K; Nakamura T; Jiang WG
    Int J Cancer; 2003 Sep; 106(3):348-54. PubMed ID: 12845672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver targeting of plasmid DNA with a cationized pullulan for tumor suppression.
    Jo J; Yamamoto M; Matsumoto K; Nakamura T; Tabata Y
    J Nanosci Nanotechnol; 2006; 6(9-10):2853-9. PubMed ID: 17048491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo release and gene expression of plasmid DNA by hydrogels of gelatin with different cationization extents.
    Kushibiki T; Tomoshige R; Fukunaka Y; Kakemi M; Tabata Y
    J Control Release; 2003 Jun; 90(2):207-16. PubMed ID: 12810303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local delivery of matrix metalloproteinase gene prevents the onset of renal sclerosis in streptozotocin-induced diabetic mice.
    Aoyama T; Yamamoto S; Kanematsu A; Ogawa O; Tabata Y
    Tissue Eng; 2003 Dec; 9(6):1289-99. PubMed ID: 14674437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic NK4 gene therapy inhibits tumor growth and metastasis of melanoma and lung carcinoma in syngeneic mouse tumor models.
    Kishi Y; Kuba K; Nakamura T; Wen J; Suzuki Y; Mizuno S; Nukiwa T; Matsumoto K; Nakamura T
    Cancer Sci; 2009 Jul; 100(7):1351-8. PubMed ID: 19438869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of HGF/NK4 in ovarian cancer cells suppresses intraperitoneal dissemination and extends host survival.
    Saga Y; Mizukami H; Suzuki M; Urabe M; Kume A; Nakamura T; Sato I; Ozawa K
    Gene Ther; 2001 Oct; 8(19):1450-5. PubMed ID: 11593357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.
    Suzuki Y; Sakai K; Ueki J; Xu Q; Nakamura T; Shimada H; Nakamura T; Matsumoto K
    Int J Cancer; 2010 Oct; 127(8):1948-57. PubMed ID: 20104519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockage of HGF/c-Met system by gene therapy (adenovirus-mediated NK4 gene) suppresses hepatocellular carcinoma in mice.
    Son G; Hirano T; Seki E; Iimuro Y; Nukiwa T; Matsumoto K; Nakamura T; Fujimoto J
    J Hepatol; 2006 Nov; 45(5):688-95. PubMed ID: 16839638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms and significance of bifunctional NK4 in cancer treatment.
    Matsumoto K; Nakamura T
    Biochem Biophys Res Commun; 2005 Jul; 333(2):316-27. PubMed ID: 15950947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene transfer of NK4, an angiogenesis inhibitor, induces CT26 tumor regression via tumor-specific T lymphocyte activation.
    Kubota T; Taiyoh H; Matsumura A; Murayama Y; Ichikawa D; Okamoto K; Fujiwara H; Ikoma H; Nakanishi M; Kikuchi S; Ochiai T; Sakakura C; Kokuba Y; Sonoyama T; Suzuki Y; Matsumoto K; Nakamura T; Otsuji E
    Int J Cancer; 2009 Dec; 125(12):2879-86. PubMed ID: 19588506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of intracerebral glioblastoma growth by local treatment with the scatter factor/hepatocyte growth factor-antagonist NK4.
    Brockmann MA; Papadimitriou A; Brandt M; Fillbrandt R; Westphal M; Lamszus K
    Clin Cancer Res; 2003 Oct; 9(12):4578-85. PubMed ID: 14555533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No influence of tumor growth by intramuscular injection of hepatocyte growth factor plasmid DNA: safety evaluation of therapeutic angiogenesis gene therapy in mice.
    Matsuki A; Yamamoto S; Nakagami H; Aoki M; Tamai K; Matsumoto K; Nakamura T; Ogihara T; Kaneda Y; Morishita R
    Biochem Biophys Res Commun; 2004 Feb; 315(1):59-65. PubMed ID: 15013425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gallbladder cancer treatment using adenovirus expressing the HGF/NK4 gene in a peritoneal implantation model.
    Tanaka T; Shimura H; Sasaki T; Narumi K; Maemondo M; Nukiwa T; Matsumoto K; Nakamura T; Ikeda S
    Cancer Gene Ther; 2004 Jun; 11(6):431-40. PubMed ID: 15118756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Suppression of peritoneal implantation by NK4 and its mechanisms].
    Atsuji K; Fujiwara H; Kubota T; Inada S; Takashima K; Yoshimura M; Ueda Y; Yamagishi H
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1777-9. PubMed ID: 15553712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.